Letko, Brosseau & Associates’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,350	Closed	-$331K	–	102
2024 Q3	$331K	Hold	11,350	–	–	0.01%	89
2024 Q2	$264K	Buy	+11,350	New	+$264K	0.01%	92